HAEMONETICS CORP (HAE) Most Active Options

The 25 most actively traded HAEMONETICS CORP (HAE) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Oct 9, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$119.17
52-week range
$48.57 – $119.17
ATM IV (30d)
38.5%
IV rank
61 / 100
Moderate
Expected move
±$6.35 (±5.3%)
Put/call OI
0.56
Call-heavy
Max pain
$105
↓ 11.9% below close
Next earnings
Nov 5, 2026

Chat with OptAI about HAE


Most Active HAE Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
HAE $125 call Oct 16, 2026 7d $0.45 35.8% 93 0.16 376 178 2.6× avg
HAE $115 put Oct 16, 2026 7d $0.66 30.9% 0 -0.22 116 94 1.0× avg
HAE $120 put Oct 16, 2026 7d $2.35 23.0% 31 -0.62 29 71 3.0× avg
HAE $140 call Mar 19, 2027 161d $7.00 45.4% 91 0.37 10 40 8.1× avg
HAE $110 put Oct 16, 2026 7d $0.29 45.9% 0 -0.11 85 31 2.0× avg
HAE $120 call Oct 16, 2026 7d $1.65 38.5% 100 0.43 25 29 0.4× avg
HAE $120 put Nov 20, 2026 42d $9.30 57.6% 100 -0.47 0 26 7.4× avg
HAE $125 put Mar 19, 2027 161d $16.40 46.2% 100 -0.48 0 17 6.5× avg
HAE $125 put Jan 15, 2027 98d $13.70 44.6% 73 -0.52 0 15 5.7× avg
HAE $130 put Jan 21, 2028 469d $26.70 44.2% 54 -0.43 1 14 11.4× avg
HAE $115 call Oct 16, 2026 7d $5.50 42.8% 0 0.72 15 12 1.0× avg
HAE $115 call Nov 20, 2026 42d $11.17 59.6% 100 0.61 525 12 1.6× avg
HAE $110 call Oct 16, 2026 7d $10.08 61.5% 0 0.83 24 12 1.1× avg
HAE $130 call Nov 20, 2026 42d $4.67 56.7% 95 0.36 544 11 0.9× avg
HAE $105 call Oct 16, 2026 7d $14.13 84.5% 100 0.87 15 10 0.9× avg
HAE $125 put Nov 20, 2026 42d $12.00 57.0% 96 -0.56 0 9 2.6× avg
HAE $120 call Nov 20, 2026 42d $9.30 58.2% 100 0.53 7 8 2.0× avg
HAE $130 put Jan 15, 2027 98d $16.40 45.0% 65 -0.59 0 7 5.7× avg
HAE $105 put Nov 20, 2026 42d $4.00 59.5% 83 -0.23 707 6 0.2× avg
HAE $145 call Nov 20, 2026 42d $2.55 55.7% 100 0.17 32 6 0.4× avg
HAE $105 call Nov 20, 2026 42d $18.30 64.1% 100 0.76 110 5 1.9× avg
HAE $110 call Nov 20, 2026 42d $13.70 62.3% 94 0.69 10 5 1.9× avg
HAE $140 put Jan 21, 2028 469d $33.00 46.1% 0 -0.48 1 4 3.0× avg
HAE $135 put Jan 21, 2028 469d $29.90 44.8% 62 -0.46 0 3 2.4× avg
HAE $90 call Jan 15, 2027 98d $32.41 53.4% 35 0.88 23 2 10.6× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active HAE contract today is the $125 call expiring in 7 days, with 178 contracts traded. Calls dominate the most-active list (13 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on HAE for free

Build multi-leg HAE strategies, visualize payoffs, and scan the full US options universe with OptiView.

HAE Options FAQ

Which HAE option contract is most active today?

The most traded HAE contract is the $125 call expiring Oct 16, 2026, with 178 contracts traded as of Oct 9, 2026.

How does OptiView rank the most active HAE options?

The table lists the 25 HAE contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.